Streamline Health Solutions, Inc. Stock

Equities

STRM

US86323X1063

Healthcare Facilities & Services

Delayed Nasdaq 01:12:11 2024-04-19 pm EDT 5-day change 1st Jan Change
0.347 USD +4.52% Intraday chart for Streamline Health Solutions, Inc. +5.15% -18.35%
Sales 2024 * 22.71M Sales 2025 * 21.88M Capitalization 18.87M
Net income 2024 * -19M Net income 2025 * -6M EV / Sales 2024 * 0.83 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 0.86 x
P/E ratio 2024 *
-0.96 x
P/E ratio 2025 *
-2.89 x
Employees 112
Yield 2024 *
-
Yield 2025 *
-
Free-Float 71.78%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Streamline Health Solutions, Inc.

1 day-7.03%
1 week-7.78%
Current month-30.83%
1 month-46.89%
3 months-12.63%
6 months-3.77%
Current year-21.88%
More quotes
1 week
0.33
Extreme 0.33
0.40
1 month
0.33
Extreme 0.33
0.63
Current year
0.31
Extreme 0.3108
0.64
1 year
0.21
Extreme 0.213
1.85
3 years
0.21
Extreme 0.213
2.35
5 years
0.21
Extreme 0.213
3.86
10 years
0.21
Extreme 0.213
5.77
More quotes
Managers TitleAgeSince
Chief Executive Officer 35 12-12-31
Director of Finance/CFO 48 20-06-30
Chairman 52 18-08-06
Members of the board TitleAgeSince
Director/Board Member 50 19-12-09
Director/Board Member 50 Feb. 06
Director/Board Member 51 05-04-30
More insiders
Date Price Change Volume
24-04-19 0.347 +4.52% 1 795
24-04-18 0.332 -7.03% 53,333
24-04-17 0.3571 +7.89% 8,544
24-04-16 0.331 -2.65% 9,913
24-04-15 0.34 +3.03% 138,890

Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT

More quotes
Streamline Health Solutions, Inc. is a provider of health information technology solutions and associated services. The Company provides computer software-based solutions, professional consulting and auditing, and coding services, which capture, aggregate, and translate structured and unstructured data to deliver intelligently organized, easily accessible predictive insights to its clients. The Company offers solutions and services to assist its clients in revenue cycle management including its two flagship technologies RevID and eValuator. RevID is a cloud-based software-as-a-service (SaaS) automated, 24-hour charge reconciliation tool. RevID identifies discrepancies between a provider’s clinical and billing departments and ensures that every medical service is tracked. eValuator Coding Analysis Platform is a cloud-based SaaS solution that delivers the capability of fully automated analysis on 100% of billing codes entered by a healthcare provider’s coding team.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.332 USD
Average target price
1.25 USD
Spread / Average Target
+276.51%
Consensus